Logo image of ALFEN.AS

ALFEN N.V. (ALFEN.AS) Stock Fundamental Analysis

AMS:ALFEN - Euronext Amsterdam - NL0012817175 - Common Stock - Currency: EUR

10.015  -0.06 (-0.6%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALFEN. ALFEN was compared to 56 industry peers in the Electrical Equipment industry. The financial health of ALFEN is average, but there are quite some concerns on its profitability. ALFEN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALFEN had negative earnings in the past year.
ALFEN had a positive operating cash flow in the past year.
Of the past 5 years ALFEN 4 years were profitable.
ALFEN had a positive operating cash flow in each of the past 5 years.
ALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFALFEN.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.45%, ALFEN is doing worse than 71.43% of the companies in the same industry.
With a Return On Equity value of -17.74%, ALFEN is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROIC N/A
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALFEN.AS Yearly ROA, ROE, ROICALFEN.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

The Gross Margin of ALFEN (31.09%) is comparable to the rest of the industry.
ALFEN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALFEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.09%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
ALFEN.AS Yearly Profit, Operating, Gross MarginsALFEN.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

ALFEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALFEN has about the same amount of shares outstanding.
The number of shares outstanding for ALFEN has been increased compared to 5 years ago.
The debt/assets ratio for ALFEN has been reduced compared to a year ago.
ALFEN.AS Yearly Shares OutstandingALFEN.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ALFEN.AS Yearly Total Debt VS Total AssetsALFEN.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 2.42 indicates that ALFEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
ALFEN has a Altman-Z score of 2.42. This is in the better half of the industry: ALFEN outperforms 75.00% of its industry peers.
ALFEN has a debt to FCF ratio of 1.59. This is a very positive value and a sign of high solvency as it would only need 1.59 years to pay back of all of its debts.
The Debt to FCF ratio of ALFEN (1.59) is better than 91.07% of its industry peers.
A Debt/Equity ratio of 0.28 indicates that ALFEN is not too dependend on debt financing.
ALFEN has a better Debt to Equity ratio (0.28) than 73.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Altman-Z 2.42
ROIC/WACCN/A
WACC7.44%
ALFEN.AS Yearly LT Debt VS Equity VS FCFALFEN.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

ALFEN has a Current Ratio of 1.68. This is a normal value and indicates that ALFEN is financially healthy and should not expect problems in meeting its short term obligations.
ALFEN's Current ratio of 1.68 is in line compared to the rest of the industry. ALFEN outperforms 58.93% of its industry peers.
A Quick Ratio of 1.00 indicates that ALFEN may have some problems paying its short term obligations.
ALFEN has a Quick ratio of 1.00. This is comparable to the rest of the industry: ALFEN outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 1
ALFEN.AS Yearly Current Assets VS Current LiabilitesALFEN.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

4

3. Growth

3.1 Past

ALFEN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -191.15%.
The Revenue has decreased by -3.34% in the past year.
ALFEN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.79% yearly.
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%

3.2 Future

The Earnings Per Share is expected to grow by 46.10% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 3.99% on average over the next years.
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y46.1%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y3.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALFEN.AS Yearly Revenue VS EstimatesALFEN.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M
ALFEN.AS Yearly EPS VS EstimatesALFEN.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 1 1.5 2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ALFEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 14.68, ALFEN is valued correctly.
Based on the Price/Forward Earnings ratio, ALFEN is valued a bit cheaper than 64.29% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.19, ALFEN is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 14.68
ALFEN.AS Price Earnings VS Forward Price EarningsALFEN.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALFEN indicates a rather cheap valuation: ALFEN is cheaper than 96.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.97
EV/EBITDA N/A
ALFEN.AS Per share dataALFEN.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALFEN's earnings are expected to grow with 101.07% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y184.12%
EPS Next 3Y101.07%

More info and screens

0

5. Dividend

5.1 Amount

ALFEN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALFEN N.V.

AMS:ALFEN (6/20/2025, 7:00:00 PM)

10.015

-0.06 (-0.6%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-20 2025-08-20
Inst Owners40.9%
Inst Owner ChangeN/A
Ins Owners0.56%
Ins Owner ChangeN/A
Market Cap217.83M
Analysts45.88
Price Target12.6 (25.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.18%
PT rev (3m)-20.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)5.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.68
P/S 0.45
P/FCF 6.97
P/OCF 3.9
P/B 1.43
P/tB 1.74
EV/EBITDA N/A
EPS(TTM)-1.24
EYN/A
EPS(NY)0.68
Fwd EY6.81%
FCF(TTM)1.44
FCFY14.35%
OCF(TTM)2.57
OCFY25.63%
SpS22.42
BVpS7
TBVpS5.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.45%
ROE -17.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.09%
FCFM 6.41%
ROA(3y)5.52%
ROA(5y)7.16%
ROE(3y)11.34%
ROE(5y)14.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.42%
GM growth 5Y-4.61%
F-Score5
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 1.59
Debt/EBITDA N/A
Cap/Depr 93.52%
Cap/Sales 5.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 1
Altman-Z 2.42
F-Score5
WACC7.44%
ROIC/WACCN/A
Cap/Depr(3y)181.87%
Cap/Depr(5y)166.2%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-178.64%
EPS Next Y527.24%
EPS Next 2Y184.12%
EPS Next 3Y101.07%
EPS Next 5Y46.1%
Revenue 1Y (TTM)-3.34%
Revenue growth 3Y25%
Revenue growth 5Y27.79%
Sales Q2Q%67.79%
Revenue Next Year1.97%
Revenue Next 2Y5.44%
Revenue Next 3Y6.31%
Revenue Next 5Y3.99%
EBIT growth 1Y-172.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year726.38%
EBIT Next 3Y136.35%
EBIT Next 5Y68%
FCF growth 1Y207.54%
FCF growth 3YN/A
FCF growth 5Y33.38%
OCF growth 1Y890.24%
OCF growth 3Y74.32%
OCF growth 5Y31.69%